Synmosa Biopharma Dividend
Dividend criteria checks 3/6
Synmosa Biopharma is a dividend paying company with a current yield of 1.56% that is well covered by earnings.
Key information
1.6%
Dividend yield
37%
Payout ratio
| Industry average yield | 1.7% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | NT$1.56 |
| Dividend yield forecast in 3Y | 1.6% |
Recent dividend updates
Recent updates
Is Synmosa Biopharma Corporation (GTSM:4114) A Smart Pick For Income Investors?
Apr 04
If You Had Bought Synmosa Biopharma (GTSM:4114) Stock Three Years Ago, You Could Pocket A 22% Gain Today
Mar 08Should Weakness in Synmosa Biopharma Corporation's (GTSM:4114) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jan 31Is Synmosa Biopharma (GTSM:4114) A Risky Investment?
Jan 05Here's Why We Don't Think Synmosa Biopharma's (GTSM:4114) Statutory Earnings Reflect Its Underlying Earnings Potential
Dec 09
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 4114's dividends per share have been stable in the past 10 years.
Growing Dividend: 4114's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Synmosa Biopharma Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (4114) | 1.6% |
| Market Bottom 25% (TW) | 1.8% |
| Market Top 25% (TW) | 4.5% |
| Industry Average (Pharmaceuticals) | 1.7% |
| Analyst forecast in 3 Years (4114) | 1.6% |
Notable Dividend: 4114's dividend (1.56%) isn’t notable compared to the bottom 25% of dividend payers in the TW market (1.78%).
High Dividend: 4114's dividend (1.56%) is low compared to the top 25% of dividend payers in the TW market (4.48%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (37.2%), 4114's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (91.2%), 4114's dividend payments are not well covered by cash flows.